Transforming the field of immune tolerance with a novel antigen-specific and targeted nanoparticle technology. Topas Therapeutics is advancing a highly differentiated and versatile approach to establish immune tolerance in autoimmune and immune-mediated diseases.
No named decision-maker yet.
Careers mailbox is known
May 6, 2024
New executive Topas Therapeutics Appoints Hugo Fry as CEO · businesswire.com
Oct 19, 2020
Raised a round Venture round $23.8M · led by Vesalius BioCapital III · YahooFinance
1993
Founded
Advanced Treg Therapy for Autoimmune Diseases. For more information, contact [email protected].
Andrew Krouse · Executive Officer, Director · decision-maker
Kurt Woerpel · Executive Officer · decision-maker
Brian Gallagher · Director
Kyparissia Sirinakis · Director
Careers mailbox is known
Dec 30, 2022
Raised a round Venture round $2.8M · SEC Form D
2020
Founded
Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.
Sai Muralidhar Padala · Executive Officer, Director · decision-maker
Lisa Heine · Director
Gowri Raman · Director
Eric Sarin · Director
No careers mailbox known
2025
Team of 17 was 12 · US Form 5500 (plan participants)
Nov 10, 2022
Raised a round Venture round $12M · SEC Form D
2018
Founded
About us At Macomics we are applying our world-leading understanding of macrophage biology in developing a proprietary pipeline of first-in-class novel therapeutics that directly modulate macrophage activity.
No named decision-maker yet.
Careers mailbox is known
Jun 10, 2024
New executive Macomics Announces Appointment of Simon Dew as New Chief Business Officer · macomics.com
Apr 11, 2024
Launched Macomics Unveils its Lead First-in-Class Anti-Pan-LILR Monoclonal Antibody Programme with Positive Pre-clinical Data Presented at AACR 2024 · macomics.com
Sep 29, 2023
Expanded Macomics Expands in Edinburgh with Move to Roslin Innovation Centre and Announces Appointment of Professor Paul Crocker to SAB · macomics.com
Mar 23, 2023
Partnership Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancer · YahooFinance
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
No named decision-maker yet.
Careers mailbox is known
Dec 15, 2025
Partnership Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering · PRNewswire
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
No named decision-maker yet.
Careers mailbox is known
2021
Founded
No named decision-maker yet.
No careers mailbox known
Kodikaz is a breakthrough pre-clinical gene therapy biotech company. Kodikaz translates cell-recognition and genomic integration mechanisms into curative therapies. Our Zip-Code Technology ™ was discovered in the lab of our scientific founder Dr. Leon Bernal-Mizrachi, at Emory Medical School.
No named decision-maker yet.
No careers mailbox known
We seed early stage and highly innovative life sciences assets to create companies based on breakthrough assets.
No named decision-maker yet.
Careers mailbox is known
Our Adenovo™ platform and 100-million-variant library move us from discovery to impact. With THEO-260 as our lead programme, our world-class team is applying world-leading science to expand access to innovative therapies that promise lasting benefit.
No named decision-maker yet.
Careers mailbox is known
Jun 1
Won a grant $5.8M · CORDIS
